Adastra Holdings Receives Flower Sales License from Health Canada

Published: January 4, 2022

Adastra Holdings Receives Flower Sales License from Health Canada

Adastra Holdings Ltd. announced that the Company’s wholly-owned subsidiary Adastra Labs Inc. (“Adastra Labs”) has received its flower sales license amendment from Health Canada effective December 17, 2021 (the “Flower Sales License”). The Flower Sales License will allow Adastra Labs to sell dried cannabis flower products provincially and territorially in Canada through authorized distributors and retailers.

“Receiving our flower sales license is a significant milestone and provides Adastra with an additional pathway to pursue higher-margin revenue growth within the Canadian cannabis market,” said Donald Dinsmore, COO & Director. “With the ability to be a direct supplier, we are now even better positioned to leverage the strong awareness and existing shelf space of our popular Phyto Extractions brand, as well as our national inside sales force, by offering an expanded portfolio of other products targeted at the cost-conscious and the premium craft consumers that will include pre-rolls and dried flower offerings.”

Dried cannabis flower is in high demand from provincial distributors and medical clients. According to Statistics Canada, dried flower sales accounted for nearly three-quarters of legal recreational cannabis sales in the first half of 2021, worth over $1.3 billion in sales.1

Michael Forbes, Chief Executive Officer of Adastra, commented, “Adastra is in a great position to maximize profits through the continued reduction in biomass costs and the little need for capital expenditure. I am particularly excited about the upcoming launch of infused pre-rolls, as they are the fastest-growing segment in the flower category. With national shelf space to leverage, the facility, and the team to execute, these new flower SKUs will propel Adastra into record sales and profitability.”

 MJBizDaily, October 20, 2021 (article)

About Adastra Holdings Ltd.
Founded in 2018 and formerly known as Phyto Extractions Inc., Adastra is a leading manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult–use and medical markets and forward–looking therapeutic applications. Adastra is renowned throughout Canada for its popular line of Phyto Extractions branded cannabis concentrate products available on shelves at over 1,400 adult–use retailers across the country. The Company also operates Adastra Labs, a 13,500 sq. ft. agricultural–scale Health Canada licensed facility located in Langley, BC., focused on extraction, distillation, and manufacturing of cannabis–derived products.

Recent News

View All News Items

Latest Article

Marrying Up Cannabis Regulations & Business Opportunities

Marrying Up Cannabis Regulations & Business Opportunities

The evolving Canadian cannabis market provides many opportunities for a variety of products and services that support the cultivation, processing and distribution of cannabis-related items. What’s more, the legal market has fostered a suitable environment for attracting the talents and expertise of legacy market employees and devotees, thus increasing the market’s ‘potency’.

Read Article